1. Home
  2. FBIN vs PCVX Comparison

FBIN vs PCVX Comparison

Compare FBIN & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortune Brands Innovations Inc.

FBIN

Fortune Brands Innovations Inc.

HOLD

Current Price

$38.57

Market Cap

6.2B

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$54.71

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBIN
PCVX
Founded
1988
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.1B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
FBIN
PCVX
Price
$38.57
$54.71
Analyst Decision
Buy
Strong Buy
Analyst Count
11
7
Target Price
$61.40
$98.33
AVG Volume (30 Days)
2.8M
1.1M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
2.69%
N/A
EPS Growth
N/A
N/A
EPS
2.47
N/A
Revenue
$4,463,200,000.00
N/A
Revenue This Year
$2.75
N/A
Revenue Next Year
$3.64
N/A
P/E Ratio
$15.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$38.20
$28.09
52 Week High
$64.84
$65.00

Technical Indicators

Market Signals
Indicator
FBIN
PCVX
Relative Strength Index (RSI) 23.30 45.69
Support Level N/A $42.30
Resistance Level $53.30 $56.04
Average True Range (ATR) 1.72 2.21
MACD -0.27 -0.39
Stochastic Oscillator 5.10 23.87

Price Performance

Historical Comparison
FBIN
PCVX

About FBIN Fortune Brands Innovations Inc.

Fortune Brands Innovations is a leading home and security products company that has three reportable segments. The company's $2.6 billion water segment, led by the Moen brand, sells faucets, showers, and other plumbing fixtures; the $1.4 billion outdoors segment primarily sells entry doors under the Therma-Tru brand name and Fiberon-branded patio decking; and the $700 million security segment sells locks and other security devices under the Master Lock, SentrySafe, Yale, and August brand names.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: